Prostate Cancer - Results from #28280

AUA 2011 - Inhibition of prostate cancer progression by dutasteride and the impact on anxiety, quality of life, and urinary symptoms in men undergoing active surveillance: REDEEM study results - Session Highlights May 16, 2011

AUA 2011 - Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality - Session Highlights May 16, 2011

AUA 2011 - Association of the number of lymph nodes (LN) removed at radical prostatectomy with all-cause (ACM) and prostate cancer-specific mortality (PCSM) - Session Highlights May 16, 2011

AUA 2011 - RRP as stand-alone therapy for high-risk prostate cancer - Session Highlights May 16, 2011

AUA 2011 - SBUR/SUO: Natural history of prostate cancer and its implications for over- and under-treatment - Session Highlights May 15, 2011

AUA 2011 - SBUR/SUO: Improving the value of PSA - Session Highlights May 15, 2011

AUA 2011 - SBUR/SUO: Grassroots collaborations to improve quality in urologic oncology - Session Highlights May 15, 2011

AUA 2011 - SBUR/SUO: Updates on novel therapies for advanced prostate cancer - Session Highlights May 15, 2011

AUA 2011 - SBUR/SUO: Case management panel: Adjuvant vs. salvage radiation: Role of decision analysis - Session Highlights May 15, 2011

AUA 2011 - SBUR/SUO: Docetaxel inhibits AR nuclear localization and activity - Session Highlights May 15, 2011

AUA 2011 - SBUR/SUO: Targeting stress-induced cytoprotective chaperones, CLU and Hsp27, in CRPC - Session Highlights May 15, 2011

AUA 2011 - SBUR/SUO: Update on targeted therapies for advanced cancer - Session Highlights May 15, 2011

AUA 2011 - SBUR/SUO: Debate: Laparoscopic vs. open retroperitoneal lymph node dissection - Session Highlights May 15, 2011

AUA 2011 - SBUR/SUO: Chemotherapy resistant breast cancer - Session Highlights May 15, 2011

AUA 2011 - SBUR/SUO: New insights into androgen receptor and ERG in prostate cancer - Session Highlights May 15, 2011

AUA 2011 - Gay men more vulnerable to quality of life impacts following prostate cancer - Press Release May 15, 2011

Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer - Abstract May 13, 2011

Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort - Abstract May 13, 2011

Progression of metastatic castrate-resistant prostate cancer: Impact of therapeutic intervention in the post-docetaxel space - Abstract May 13, 2011

Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate - Abstract May 13, 2011

Page 1415 of 1451